Daver, N.g., Wei, A.h., Stein, E.m., Deangelo, D.j., Pathak, D., Xu, Y., et al. (2022). AML-143 Trial in Progress: Phase Ib/II Study of Siremadlin in Combination With Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy (IC). CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 22, 217-217 [10.1016/S2152-2650(22)01228-9].
AML-143 Trial in Progress: Phase Ib/II Study of Siremadlin in Combination With Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy (IC)
Venditti A.
2022-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
